{"title":"Structural elucidation, nuclease activity, protein binding, docking, and ADMET studies of nickel, copper, and zinc complexes","authors":"Deepa Krishnan, Angappan Sheela","doi":"10.1016/j.poly.2025.117886","DOIUrl":null,"url":null,"abstract":"<div><div>This study outlines the synthesis, comprehensive characterisation, and assessment of anticancer efficacy of three mononuclear aldimine-based nickel, copper, and zinc complexes. The complexes are characterised by FTIR, UV–Vis, <sup>1</sup>H, <sup>13</sup>C NMR, EPR, and HR-MS spectral techniques. The 6-311G/LanL2DZ ECP basis set and the B3LYP optimise the molecular structures and geometries of the ligands and complexes. The UV absorption titration and fluorescence quenching experiments evaluate the relative binding propensity profiles of the compounds with DNA and BSA. From the results of the UV method, it has been observed that the nickel complex shows a stronger affinity with CT-DNA, having the intrinsic binding constant (K<sub>b</sub>) of 9.26 × 10<sup>5</sup> M<sup>−1</sup><sub>,</sub> than other complexes. However, in the competitive displacement assay with ethidium bromide, the copper complex, preferably, shows higher binding interactions, with the Stern-Volmer constant (K<sub>sv</sub>) value of 4.4 × 10<sup>3</sup> M<sup>−1</sup>, than other complexes. In the fluorescence quenching assay with BSA, only the nickel complex shows a Stern-Volmer quenching constant (K<sub>BSA</sub>) value of 6.4401 × 10<sup>4</sup> M<sup>−1</sup>, higher than the other complexes. The molecular docking indicated that the compounds possess high binding energy, supporting the experimental observations. The pHarmacokinetics and drug-like behaviour of the compounds are ascertained theoretically by ADMET studies.</div></div>","PeriodicalId":20278,"journal":{"name":"Polyhedron","volume":"284 ","pages":"Article 117886"},"PeriodicalIF":2.8000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polyhedron","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0277538725005005","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, INORGANIC & NUCLEAR","Score":null,"Total":0}
引用次数: 0
Abstract
This study outlines the synthesis, comprehensive characterisation, and assessment of anticancer efficacy of three mononuclear aldimine-based nickel, copper, and zinc complexes. The complexes are characterised by FTIR, UV–Vis, 1H, 13C NMR, EPR, and HR-MS spectral techniques. The 6-311G/LanL2DZ ECP basis set and the B3LYP optimise the molecular structures and geometries of the ligands and complexes. The UV absorption titration and fluorescence quenching experiments evaluate the relative binding propensity profiles of the compounds with DNA and BSA. From the results of the UV method, it has been observed that the nickel complex shows a stronger affinity with CT-DNA, having the intrinsic binding constant (Kb) of 9.26 × 105 M−1, than other complexes. However, in the competitive displacement assay with ethidium bromide, the copper complex, preferably, shows higher binding interactions, with the Stern-Volmer constant (Ksv) value of 4.4 × 103 M−1, than other complexes. In the fluorescence quenching assay with BSA, only the nickel complex shows a Stern-Volmer quenching constant (KBSA) value of 6.4401 × 104 M−1, higher than the other complexes. The molecular docking indicated that the compounds possess high binding energy, supporting the experimental observations. The pHarmacokinetics and drug-like behaviour of the compounds are ascertained theoretically by ADMET studies.
期刊介绍:
Polyhedron publishes original, fundamental, experimental and theoretical work of the highest quality in all the major areas of inorganic chemistry. This includes synthetic chemistry, coordination chemistry, organometallic chemistry, bioinorganic chemistry, and solid-state and materials chemistry.
Papers should be significant pieces of work, and all new compounds must be appropriately characterized. The inclusion of single-crystal X-ray structural data is strongly encouraged, but papers reporting only the X-ray structure determination of a single compound will usually not be considered. Papers on solid-state or materials chemistry will be expected to have a significant molecular chemistry component (such as the synthesis and characterization of the molecular precursors and/or a systematic study of the use of different precursors or reaction conditions) or demonstrate a cutting-edge application (for example inorganic materials for energy applications). Papers dealing only with stability constants are not considered.